Agenda at a glance
All times in CEST Stockholm


The full agenda will be updated with speakers and companies over the coming weeks.


LIVE = Real-time content with audience Q&A (becomes on-demand once held)
ON-DEMAND = Evergreen content that can be watched anytime to fit around your schedule
INTERACTIVE = Live, peer-to-peer grouped sessions allowing multi-way discussion

1:1 PARTNERING = Private and secure video-enabled networking and meeting

To review everything taking place at LSX Nordic Congress Virtual - check out the brochure!

 

Day 1 - 1st September

09:00

ON-DEMAND: SHOWCASES AND VIRTUAL BOOTHS (available all-day)

09:15

LIVE: OPENING PANEL (40 Mins) Cultivating a sustainable ecosystem and companies with long-term amibitions in the Nordics

Key stakeholders from across the region discuss how the Nordic ecosystem is evolving and what more can be done to finance, invest and build the Nordic cluster with a great proportion of larger companies with long-term ambitions, to complement and support the thriving startup and growth stage community.

  • Adam Kostyál, SVP, Nasdaq
  • Nikolaj Sørensen, CEO, Orexo
10:00

1:1 PARTNERING OPENS (24 Hrs)

10:15

LIVE: PUBLIC CEO FORUM (2 Hrs)

Hosted by:      Nasdaq 300x150-1       Vinge Update-1

10:30

ON-DEMAND: KEYNOTE PANEL (45 Mins) Investing in Healthtech & Digital Health - The next wave of Nordic innovation

Healthtech and digital health technologies are starting to realise their promise and make meaningful impacts across the life science and healthcare space, and the Nordic countries are among Europe’s leaders in the digital healthcare revolution. Investors and executives discuss the local and international investment landscape in digital and health technology and how the Nordics can lead the way in innovation.

  • Patrik Sobocki, Investment Manager, Industrifonden
  • Klaus Stöckemann, Managing Partner, Peppermint VP
  • Andreas Lindblom, CEO, Sciety
13:00

ON-DEMAND: PANEL (1 Hr) What’s hot in early stage investment?

Expert early-stage investors highlight where they see the exciting and hot new areas before settling in as judges of the Inv¤$table Startups in Stockholm competition for the Nordic region’s life science and healthcare innovators!

  • Karl Xavier, Partner, Axilium Capital
  • Andreas Lindblom, CEO, Sciety
  • Andreas Jurgeit, Partner, Lundbeckfonden Emerge
  • Ingrid Akay, Managing Partner, Hadean Ventures
  • Maria Tell, Investment Manager, Life Sciences, Almi Invest 
14:00

LIVE: PRIVATE CEO FORUM (1 Hr 45 Mins)

Hosted by:       Nasdaq 300x150-1Mintz 300x150

16:00

LIVE: CLOSING PANEL (45 Mins) Panel: Global syndication and expanding your international investor base

  • Stephan Christgau, Partner, Eir Ventures
  • Rafaèle Tordjman, Founder & CEO, Jeito
  • Thierry Laugel, Managing Partner, Kurma Partners
  • Sascha Alilovic, Managing Partner, SHS 
16:45

INTERACTIVE: VIRTUAL NETWORKING RECEPTION

Day 2 - 2nd September

09:00

1:1 PARTNERING RE-OPENS (24 Hrs)

09:20

LIVE: WELCOME ADDRESS (25 Mins) Swedish Life Sciences Strategy

  • Jenni Nordborg, Head of the Office for Life Sciences, Government Offices of Sweden
09:45

LIVE: KEYNOTE PANEL (45 Mins) Coming out the other side: Perspectives on life science strategies, private and public financing partnerships and M&A in the aftermath post-COVID-19

The COVID-19 outbreak has sent shockwaves through the world, disrupting every industry and creating uncertainties in financial markets. The life sciences and healthcare is in a unique position with some companies pivoting to help in the fight against the virus, others business plans being severely disrupted, and both public and private investors in the sector navigating an untrodden path. A cross-stakeholder panel discusses • What has been the impact on investors portfolio companies, investment strategies and appetite in the short and medium term? • How and where will changes in the public and private capital available to companies affect wider industry M&A activity? • Could Pharma partnering strategies change? How can companies best position themselves to come out stronger?

  • Ulrica Slåne Bjerke, CIO, Arctic Aurora LifeScience
11:00

LIVE: CLINICAL STRATEGIES WORKSHOP (1 Hr 30 Mins)

12:45

ON-DEMAND: PANEL (45 Mins) What’s attracting Big Pharma right now?

Partnering up with big pharma or other life science companies can make cost savings and pool resources and expertise, but for public companies are not without risk. Executives of public companies with licencing, co-development and R&D partnerships share their stories of securing these deals and discuss effective deal structures, mitigating risks in asset dilution and commercialisation rights and how to drive shareholder value through optimising these partnerships.

  • Gunilla Osswald, CEO, BioArctic
  • Don deBethizy, Director, Argenx 
16:00

LIVE: CLOSING PANEL (45 Mins) Developing and optimising pharma partnerships across biotech, medtech and healthtech innovation

The potentially transformative nature of partnership a big pharma is well documented but is not without its risks and challenges and partnerships and deals differ between private and public companies. Pharma continue to be hungry to source innovation and build win-win partnerships with the latest technologies to supplement and complement internal R&D. Heads of innovation, search and evaluation and business development from big Pharma discuss the role pharma companies are taking in supporting younger companies and the evolving strategies in all life science and technology partnerships and deals.

  • Phil L’Huillier, Head of BD, Europe, European Innovation Hub, MSD
  • Ingalill Hyltander, Commercial Operation Director Pharma Scandinavia, Bayer
  • Mats Berggren, Director, Digital Business Innovation & External Collaboration Models, M-Digital Lead, Merck KGaA
16:45

INTERACTIVE: VIRTUAL SYNDICATION RECEPTION

 

Day 3 - 3rd September

 

09:00

1:1 PARTNERING RE-OPENS (24 Hrs)

09:00

ON-DEMAND: ALL PANEL CONTENT FROM DAY 1 & 2

ON-DEMAND: SHOWCASES AND VIRTUAL BOOTHS (available all-day)

16:30

INTERACTIVE: VIRTUAL NETWORKING RECEPTION

Day 4 - 4th September

 

09:00

1:1 PARTNERING RE-OPENS (24 Hrs)

09:00

ON-DEMAND: ALL PANEL CONTENT FROM DAY 1 & 2

ON-DEMAND: SHOWCASES AND VIRTUAL BOOTHS (available all-day)

16:30

INTERACTIVE: VIRTUAL NETWORKING RECEPTION

 


 

CONTENT ONLY PASS


Suitable for all ticket types

- Access to all live, on-demand and suitable interactive sessions plus company showcases (no 1:1 partnering or virtual networking reception access)

 

REGISTER FOR  FREE